JPMorgan Downgrades Infinity Pharmaceutical (INFI) to Neutral
Tweet
Share
E-mailGet Alerts INFI Hot Sheet
Price: $0.04 --0%
Rating Summary:
12 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 20
Rating Summary:
12 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 20
Join SI Premium – FREE
JPMorgan downgraded Infinity Pharmaceutical (NASDAQ: INFI) from Overweight to Neutral.
For an analyst ratings summary and ratings history on Infinity Pharmaceutical click here. For more ratings news on Infinity Pharmaceutical click here.
Shares of Infinity Pharmaceutical closed at $4.41 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GLJ Research Downgrades Fluence Energy Inc. (FLNC) to Hold
- Macquarie Downgrades Kuaishou Technology (1024:HK) to Underperform
- BofA Securities Downgrades Gerdau S.A. (GGBR4:BZ) (GGB) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
